Stay updated on Durvalumab and Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.

Latest updates to the Durvalumab and Daratumumab in MM Clinical Trial page
- Check4 days agoChange DetectedRelated topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the page. The change affects navigation context but not the study details or results.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.2 updated from v3.2.0. This appears to be a minor, maintenance-related change with no visible edits to the study page.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page now includes the 'Multiple myeloma' topic and related MedlinePlus Genetics links, and the funding-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check33 days agoChange DetectedThe page now omits the disease term 'Multiple Myeloma' and its genetics-related topics. This reduces the disease context and access to related resources on the study page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page's related topics under MedlinePlus were reduced, removing the items 'Multiple myeloma' and 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check54 days agoChange Detected- The page adds a MedlinePlus Genetics topic: Multiple myeloma. This expands the page’s coverage to include a genetics-focused overview of this blood cancer, highlighting its genetic aspects for readers seeking authoritative medical information.SummaryDifference0.2%

Stay in the know with updates to Durvalumab and Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Daratumumab in MM Clinical Trial page.